The Therapeutic Goods Administration (TGA) has today provisionally approved a booster dose of the Pfizer COVID-19 vaccine (COMIRANTY) for Australians aged 18 years and older.
The provisional approval means adults may receive a booster shot (third dose) of the Pfizer vaccine at least six months after being fully vaccinated, even if the first two doses were AstraZeneca or Moderna shots.
In addition, consistent with Australian Technical Advisory Group on Immunisation (ATAGI) advice, the TGA says a third dose may be given to severely immunocompromised people aged 12 years and over at least 28 days after the second dose.
“TGA provisionally approved the booster dose following careful evaluation of the available data supporting safety and efficacy,” the TGA said.
“The TGA's decision was also informed by expert advice from the Advisory Committee on Vaccines, an independent committee with scientific, clinical and consumer representation.
“The Australian Government's priority continues to be completion of a two-dose vaccination schedule as this enables strong protection against severe illness and hospitalisation. Further information on the vaccine roll out will subsequently be published on the Department of Health's website.”
Updated at 9.32am AEDT on 27 October 2021.
Get our daily business news
Sign up to our free email news updates.